1. Home
  2. FPAY vs FGEN Comparison

FPAY vs FGEN Comparison

Compare FPAY & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FPAY
  • FGEN
  • Stock Information
  • Founded
  • FPAY 2003
  • FGEN 1993
  • Country
  • FPAY United States
  • FGEN United States
  • Employees
  • FPAY N/A
  • FGEN N/A
  • Industry
  • FPAY Diversified Commercial Services
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • FPAY Consumer Discretionary
  • FGEN Health Care
  • Exchange
  • FPAY Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • FPAY 27.2M
  • FGEN 33.5M
  • IPO Year
  • FPAY N/A
  • FGEN 2014
  • Fundamental
  • Price
  • FPAY $1.04
  • FGEN $7.03
  • Analyst Decision
  • FPAY Strong Buy
  • FGEN Strong Buy
  • Analyst Count
  • FPAY 2
  • FGEN 1
  • Target Price
  • FPAY $3.25
  • FGEN $250.00
  • AVG Volume (30 Days)
  • FPAY 96.0K
  • FGEN 43.0K
  • Earning Date
  • FPAY 08-05-2025
  • FGEN 08-12-2025
  • Dividend Yield
  • FPAY N/A
  • FGEN N/A
  • EPS Growth
  • FPAY N/A
  • FGEN N/A
  • EPS
  • FPAY N/A
  • FGEN N/A
  • Revenue
  • FPAY $139,800,732.00
  • FGEN $6,996,000.00
  • Revenue This Year
  • FPAY $16.58
  • FGEN N/A
  • Revenue Next Year
  • FPAY N/A
  • FGEN N/A
  • P/E Ratio
  • FPAY N/A
  • FGEN N/A
  • Revenue Growth
  • FPAY 19.51
  • FGEN N/A
  • 52 Week Low
  • FPAY $0.84
  • FGEN $4.50
  • 52 Week High
  • FPAY $2.37
  • FGEN $29.00
  • Technical
  • Relative Strength Index (RSI)
  • FPAY 36.61
  • FGEN 50.17
  • Support Level
  • FPAY $0.84
  • FGEN $7.04
  • Resistance Level
  • FPAY $1.37
  • FGEN $7.56
  • Average True Range (ATR)
  • FPAY 0.10
  • FGEN 0.49
  • MACD
  • FPAY -0.00
  • FGEN -0.00
  • Stochastic Oscillator
  • FPAY 9.30
  • FGEN 12.53

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: